Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance

Cancers - Switzerland
doi 10.3390/cancers6010193
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

STAT1 Ser727 – Key Regulator for NK Cell-Mediated Cytotoxicity and Tumor Surveillance

BMC Pharmacology
2008English

Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology
AllergyImmunology
2012English

Deficiency of GMDS Leads to Escape From NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling

Gastroenterology
HepatologyGastroenterology
2009English

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Journal of Immunology
AllergyImmunology
2007English

A Case of Cutaneous NK Cell Lymphoma.

Skin Cancer
2001English

NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.

Cancer immunology research
Cancer ResearchImmunology
2018English

Nk/T-Cell Lymphoma, the French Experience.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Loss of Function Mutations in PTPN6 Promote STAT3 Deregulation via JAK3 Kinase in Diffuse Large B-Cell Lymphoma

Oncotarget
Oncology
2015English

EBV-negative Aggressive NK-cell Leukemia/Lymphoma

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy